Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease

Journal of Vascular Surgery

Volumn 46, Issue 1, 2007, Pages 62-70

  Thatipelli, Mallik R ^a   Pellikka, Patricia A ^a   McBane, Robert D ^a   Rooke, Thom W ^a   Rosales, Gabriela A ^a   Hodge, David ^a   Herges, Regina M ^a   Wysokinski, Waldemar E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; PATIENT REFERRAL; PATIENT SELECTION; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROGNOSIS; STRESS ECHOCARDIOGRAPHY;

AGED; ANKLE; ASPIRIN; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, STRESS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 34250828365     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.03.022     Document Type: Article

References (40)

1. Yusuf S., Reddy S., Ounpuu S., and Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104 (2001) 2746-2753
2. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
3. Stoffers H.E., Rinkens P.E., Kester A.D., Kaiser V., and Knottnerus J.A. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 25 (1996) 282-290
4. Hertzer N.R., Beven E.G., Young J.R., O'Hara P.J., Ruschhaupt III W.F., Graor R.A., et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 (1984) 223-233
5. Mukherjee D., Eagle K.A., and Smith D.E. Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions. Am J Cardiol 92 (2003) 972-974
6. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
7. Caruana M.F., Bradbury A.W., and Adam D.J. The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. Eur J Vasc Endovasc Surg 29 (2005) 443-451
8. McKenna M., Wolfson S., and Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87 (1991) 119-128
9. Vogt M.T., McKenna M., Wolfson S.K., and Kuller L.H. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis 101 (1993) 191-202
10. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.F., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
11. Doobay A.V., and Anand S.S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes. A systematic review. Arterioscler Thromb Vasc Biol 25 (2005) 1463-1469
12. Geleijnse M.L., Fioretti P.M., and Roelandt J.R.T.C. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 30 (1997) 595-606
13. Anthopoulos L.P., Bonou M.S., Kardaras F.G., Sioras E.P., Kardara D.N., Sideris A.M., et al. Stress echocardiography in elderly patients with coronary artery disease. J Am Coll Cardiol 28 (1996) 52-59
14. Marwick T., Willemart B., D'Hondt A.M., Baudhuin T., Wijns W., Detry J.M., et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87 (1993) 345-354
15. Sawada S.G., Seger D.S., Ryan T., Brown S.E., Dohan A.M., Williams R., et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83 (1991) 1605-1614
16. Poldermans D., Fioretti P.M., Forster T., Thomson I.R., Boersma E., el-Said E.M., et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 87 (1993) 1506-1512
17. Lane R.T., Sawada S.G., Segar D.S., Ryan T., Lalka S.G., Williams R., et al. Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol 68 (1991) 976-977
18. Chuah S.C., Pellikka P.A., Roger V.L., McCully R.B., and Seward J.B. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 97 (1998) 1474-1480
19. Chaowalit N., Maalouf J.F., Rooke T.W., Barnes M.E., Bailey K.R., and Pellikka P.A. Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease. Am J Cardiol 94 (2004) 1523-1528
20. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
22. Therneau T., Sicks J., Bergstralh E., and Offord J. Expected survival based on hazard rates. Section of biostatistics (1994), Mayo Clinic, Rochester, Minn Technical report series. No. 52. March
23. Wysokinski W.E., Spittell P.C., Pellikka P.A., Miller W.L., and Seward J.B. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?. Intern Angiology 17 (1998) 201-207
24. Pellikka P.A., Roger V.L., Oh J.K., Miller F.A., Seward J.B., and Tajik A.J. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 70 (1995) 16-27
25. Quinones M., Wagoner A., Reduto L., Nelson J.G., Young J.B., Winters Jr. W.L., et al. A new, simplified and accurate method for determining ejection fraction with 2-dimentional echocardiography. Circulation 64 (1981) 744-753
26. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
27. Gillum R.F., Fortmann S.P., Prineas R.J., and Kottke T.E. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 108 (1984) 150-158
28. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
29. Cotter G., Cannon C.P., and McCabe C.H. OPUS-TIMI 16 Investigators. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J 145 (2003) 622-627
30. Sutton-Tyrrell K., Rihal C., Sellers M.A., Burek K., Trudel J., Roubin G., et al. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol 81 (1998) 375-381
31. Rihal C.S., Sutton-Tyrrell K., Guo P., Keller N.M., Jandova R., Sellers M.A., et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation 100 (1999) 171-177
32. Eagle K.A., Rihal C.S., Foster E.D., and the Coronary Artery Surgery Study (CASS) Investigators. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. J Am Coll Cardiol 23 (1994) 1091-1095
33. Papamichael C.M., Lekakis J.P., Stamatelopoulos K.S., Papaioannou T.G., Alevizaki M.K., Cimponeriu A.T., et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 86 (2000) 615-618
34. van der Meer I.M., Bots M.L., Hofman A., del Sol A.I., van der Kuip D.A., and Witteman J.C. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction. The Rotterdam Study. Circulation 109 (2004) 1089-1094
35. Boneu B., Leger P., and Arnaud C. Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Blood Coagul Fibrinolysis 9 (1998) 129-135
36. Shankar V.K., Chaudhury S., Ray S., Uthappa M.C., Handa A., and Hands L.J. Changes in blood coagulability as it traverses the ischemic limb. J Vasc Surg 39 (2004) 1033-1042
37. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
38. Mukherjee D., Topol E.J., Moliterno D.J., Brennan D.M., Ziada K., Cho L., and CREDO Investigators. Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment. Heart 92 (2006) 49-51
39. CHARISMA Investigators. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med 354 (2006) 1706-1717
40. Undas A., Brummel-Ziedins K.E., and Mann K.G. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 25 (2005) 287-294